MedTech News
.................... by Andrew Celentano
Tumor-on-a-chip reveals how pancreatic cancer interacts with scar tissue and resists treatment
Researchers developed a “tumor-on-a-chip” system designed to recreate that environment outside the human body, offering a more realistic way to study the disease and evaluate treatments.
AI computation enables clearer views of the deep brain, bypassing the need for expensive equipment
Professor Iksung Kang (School of Electrical Engineering), in collaboration with Professor Na Ji’s research team at UC Berkeley, has developed a technology that accurately corrects image aberrations in microscopes used for live biological imaging.
PreludeDx Receives FDA Breakthrough Device Designation for AidaBREAST® – Early-Stage Invasive Breast Cancer Assay
LAGUNA HILLS, Calif., April 29, 2026 /PRNewswire/ — Prelude Corporation (PreludeDx™), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the AidaBREAST® test.
Chest Wall Innovations Receives FDA 510(k) Clearance for PC Fix Rib Fixation System
HERSHEY, Pa., April 29, 2026 /PRNewswire/ — Chest Wall Innovations, a medical device company focused on advancing the standard of care in chest wall surgery, today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its PC Fix Rib Fixation System on April 24, 2026, clearing the path for U.S. commercialization.
Harnessing the Power of AI to Fight Lyme Disease
An anonymous gift helped Tufts researchers speed up a project to develop new drugs that could prevent and treat Lyme disease
First-Ever Smell Map Is a Breakthrough in Sensory Research, a Step to Help Us Tackle Loss of Smell
Discover how smell receptors in our noses aren’t randomly arranged but are highly organized, offering new paths toward treating sensory impairment.
Medtronic wins CE mark for Stealth AXiS surgical robot platform
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Stealth AXiS surgical robot platform.
Abbott earns FDA clearance, CE mark for next-gen coronary imaging platform
Abbott (NYSE:ABT) announced today that it received FDA clearance and CE mark for its next-generation Ultreon 3.0 software.